心肌细胞HIPK2通过ERK信号维持基础心脏功能
该研究通过整合转录组学与生物信息学分析筛选出心肌细胞HIPK2作为心力衰竭新候选激酶,并利用心肌细胞特异性HIPK2敲除和杂合小鼠模型发现HIPK2减少导致年龄依赖性心脏功能障碍,且在人终末期缺血性心肌病中HIPK2表达显著降低;机制上HIPK2缺失损害ERK1/2信号,而AAV9介导的MEK1持续激活可近乎消除敲除小鼠的有害表型。
要点
- 心肌细胞HIPK2缺失导致年龄依赖性心脏功能障碍,呈基因剂量效应。
- 人终末期缺血性心肌病中HIPK2表达较非衰竭心肌显著降低。
- HIPK2通过维持ERK1/2信号抑制心肌细胞凋亡来保护心脏功能。
核心结论
- 心肌细胞HIPK2通过细胞外信号调节激酶信号通路维持正常心脏功能。
研究设计与样本
- 研究采用整合转录组学与生物信息学分析筛选候选激酶,并构建心肌细胞特异性HIPK2敲除和杂合小鼠模型。
主要发现
- 心肌细胞HIPK2敲除和杂合小鼠均出现心脏功能障碍,且呈基因剂量效应关系。
- HIPK2敲除小鼠的心脏功能障碍随年龄增长而发展,而非在发育期出现。
- 人终末期缺血性心肌病中HIPK2表达较非衰竭心肌显著降低。
- 体外实验显示HIPK2过表达抑制NPPA和NPPB表达并消除苯肾上腺素诱导的病理基因表达。
- HIPK2缺陷心脏中ERK1/2信号受损,AAV9-TnT-MEK1-CA rescue近乎消除敲除小鼠的有害表型。
临床怎么用
- HIPK2可作为心力衰竭潜在治疗靶点,但其临床转化需进一步验证。
局限性
- 研究主要基于小鼠模型和体外实验,人类数据仅限表达观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac kinases play a critical role in the development of heart failure, and represent potential tractable therapeutic targets. However, only a very small fraction of the cardiac kinome has been investigated. To identify novel cardiac kinases involved in heart failure, we used an integrated transcriptomics and bioinformatics analysis and identified Homeodomain-Interacting Protein Kinase 2 (HIPK2) as a novel candidate kinase. The role of HIPK2 in cardiac biology is unknown. METHODS: We used the Expression2Kinase algorithm for the screening of kinase targets. To determine the role of HIPK2 in the heart, we generated cardiomyocyte (CM)-specific HIPK2 knockout and heterozygous mice. Heart function was examined by echocardiography, and related cellular and molecular mechanisms were examined. Adeno-associated virus serotype 9 carrying cardiac-specific constitutively active MEK1 (TnT-MEK1-CA) was administrated to rescue cardiac dysfunction in CM-HIPK2 knockout mice. RESULTS: To our knowledge, this is the first study to define the role of HIPK2 in cardiac biology. Using multiple HIPK2 loss-of-function mouse models, we demonstrated that reduction of HIPK2 in CMs leads to cardiac dysfunction, suggesting a causal role in heart failure. It is important to note that cardiac dysfunction in HIPK2 knockout mice developed with advancing age, but not during development. In addition, CM-HIPK2 knockout mice and CM-HIPK2 heterozygous mice exhibited a gene dose-response relationship of CM-HIPK2 on heart function. HIPK2 expression in the heart was significantly reduced in human end-stage ischemic cardiomyopathy in comparison to nonfailing myocardium, suggesting a clinical relevance of HIPK2 in cardiac biology. In vitro studies with neonatal rat ventricular CMscorroborated the in vivo findings. Specifically, adenovirus-mediated overexpression of HIPK2 suppressed the expression of heart failure markers, NPPA and NPPB, at basal condition and abolished phenylephrine-induced pathological gene expression. An array of mechanistic studies revealed impaired extracellular signal-regulated kinase 1/2 signaling in HIPK2-deficient hearts. An in vivo rescue experiment with adeno-associated virus serotype 9 TnT-MEK1-CA nearly abolished the detrimental phenotype of knockout mice, suggesting that impaired extracellular signal-regulated kinase signaling mediated apoptosis as the key factor driving the detrimental phenotype in CM-HIPK2 knockout mice hearts. CONCLUSIONS: Taken together, these findings suggest that CM-HIPK2 is required to maintain normal cardiac function via extracellular signal-regulated kinase signaling.
引用
- Guo Y, Sui JY, Kim K, et al. Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling. Circulation. 2019. PMID: 31581792. doi:10.1161/CIRCULATIONAHA.119.040740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。